A 2016 trial assessed the cardiovascular safety of the COX-2 inhibitor celecoxib relative to the nonspecific COX inhibitors ibuprofen and naproxen. The study findings suggest that in moderate doses, celecoxib is no less safe than ibuprofen or naproxen.   Reports have suggested that higher doses of the non-steroidal anti-inflammatory drug (NSAID) celecoxib – used to … Continue reading Cardiovascular Risks of Common Arthritis Drugs